A vs B [Design Issues]

posted by mittyri – Russia, 2020-02-03 21:05 (843 d 17:11 ago) – Posting: # 21136
Views: 2,516

Hi John,

citing our Hero:

If one is really interested in λz and has no SD-phase in the study, sampling should continue until concentrations from previous doses are washed out – I would expect any estimate within the MD-profile to be biased towards faster elimination.

» I have seen both designs but I (and my former bosses) prefer method A. The only drawback I see from A is it takes longer time.

why does A take longer time?


Edit: Changed to internal link; see also this post #7[Helmut]

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,108 posts in 4,630 threads, 1,567 registered users;
online 11 (1 registered, 10 guests [including 4 identified bots]).
Forum time: Friday 15:16 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5